Gelstat Stock

Gelstat ROE

The Return on Equity (ROE) of Gelstat (GSAC) as of Aug 6, 2026 is 26.12 %. In the previous year, Return on Equity (ROE) was 35.60 % — a change of -26.61% (lower).

ROE

26.12 %

YoY

-26.61%

Last updated:

In 2026, Gelstat's return on equity (ROE) was 26.12 %, a -26.61% increase from the 35.60 % ROE in the previous year.

Access this data via the Eulerpool API

Gelstat Stock analysis

What does Gelstat do? The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry. Gelstat is one of the most popular companies on Eulerpool.

ROE Details

Decoding Gelstat's Return on Equity (ROE)

Gelstat's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Gelstat's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Gelstat's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Gelstat’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Gelstat stock

Return on Equity (ROE) of Gelstat is 26.12 % in 2026.

Return on Equity (ROE) of Gelstat changed from 35.60 % to 26.12 %, representing a -26.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Gelstat since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Gelstat with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Gelstat

All Key Metrics — Gelstat